| Sentara Health Plans | Treatment for Varicose Veins of the Lower - Commercial | |
| Sentara Health Plans | Treatment for Varicose Veins of the Lower - Medicaid | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Omalizumab (Xolair) and Omalizumab Biosimilars | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Natalizumab (Tysabri) | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Valoctocogene Roxaparvovec-rvox (Roctavian) | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Granulocyte Colony-Stimulating Factors | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Ocrelizumab (Ocrevus) and Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo) | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Interleukin-23 Antagonists | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Complement Inhibitors | |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Hemophilia Treatment Clotting Factors/Coagulant Blood Products | |